Intensity Therapeutics Inc Sustainability Reports
Intensity Therapeutics, Inc. is a clinical-stage biotechnology company that develops novel cancer immunotherapies. The company specializes in creating proprietary intratumoral injections designed to kill tumors and induce systemic anti-cancer immune responses.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
2 reports from 2023 to 2024
Company Profile
Intensity Therapeutics, Inc. is a clinical-stage biotechnology company that develops novel cancer immunotherapies. The company specializes in creating proprietary intratumoral injections designed to kill tumors and induce systemic anti-cancer immune responses.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
